The Bahamas Like Grenada and Guyana, The Bahamas analyses were heavily influenced by data availability. Estimates of benefits were limited to 4 areas; excise revenues from marijuana sales, estimates of revenues from marijuana licenses fees, fees collected from marijuana possession and costs averted from marijuana possession arrests. As seen in Table 4, estimates of excise revenues from marijuana sales were between BSD$ 180,930 for model 3 year 1 and BSD$ 207,240 for model 2 year 2. By far, the largest benefit was costs averted from marijuana-related possession arrests, these ranged between BSD$ 455,080 for model 3 year 2 and BSD$ 3,416,060 for model 2 year 1. Moreover, much like the other countries, marijuana-related vehicular accidents costs were more severe then marijuana-related health costs, ranging between BSD$5498 for model 1 year 2 and BDS$ 248,475 for model 3 year 2. By way of comparison, marijuana-related health costs ranged between BSD$2,239 in model 1, year 2 and BSD$888,459 for model 3 year 1. Table 4: Estimated Costs and Benefits, The Bahamas Model 2: Benefits
Excise revenues on marijuana sales Cost averted from marijuana possession arrests(BDS$) Revenues collected from marijuana possession charges Additional Revenues from marijuanarelated license fees (EC$)
Model 1: Decriminalization of Marijuana Use, with Supply Remaining Illegal 2019
Full Legalization of Marijuana Production, Sale and Use, with State Control
2020
3,233,057 1,589,112
311,531
203,567
102
Model 3: Full Legalization of Marijuana Production Sale and Use within a Competitive Market System
2019
2020
2019
2020
184,738
207,240
180,930
200,117
3,416,060
489,726
2,515,075
455,080
872,287
54,861
642,221
68,093
308,651
328,516
325,925
369,110